Non-Small-Cell Lung Cancer Drug Market Is Estimated To Expand Further At A CAGR Of 8.10% From 2024 To 2033
As per the current market research conducted by the CMI Team, the global NSCLC Drug Market size is expected to record a CAGR of 8.1% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 34,175.6 Million. By 2033, the valuation is anticipated to reach USD 68,888.6 Million.
NSCLC Drug Market: Growth Factors and Dynamics...